Completed × Observational × Carcinoma, Renal Cell × Clear all ZEBRA
Completed
100 enrolled
TraveraRTGx
Completed
72 enrolled
VolUS3D
Completed
53 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
KIDCaD
Completed
1,000 enrolled
ADONIS
Completed
554 enrolled
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Completed
494 enrolled
RREIN
Completed
60 enrolled
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Completed
22 enrolled
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
Completed
20 enrolled
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Completed
105 enrolled 11 charts
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
Completed
746 enrolled
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
Completed
1,437 enrolled
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Completed
13 enrolled 14 charts
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
Completed
499 enrolled
AUR87A
Completed
280 enrolled
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
Completed
10 enrolled
Clinical Study of 18F -FAPI-RGD in Renal Tumor
Completed
35 enrolled
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
Completed
388 enrolled 20 charts
J-DART2
Completed
171 enrolled 36 charts
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Completed
232 enrolled
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Completed
1,474 enrolled
REVOLUTION
Completed
200 enrolled
CRYO-BO-2021
Completed
955 enrolled
A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
Completed
286 enrolled
HPGD-ccRCC
Completed
40 enrolled
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
Completed
1,922 enrolled
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Completed
481 enrolled 14 charts
ROOT
Completed
167 enrolled
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
Completed
1,200 enrolled
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Completed
180 enrolled
REMEDY
Completed
146 enrolled
IMNR
Completed
99 enrolled
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Completed
1,112 enrolled 16 charts
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Completed
1,050 enrolled 9 charts
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Completed
355 enrolled 23 charts
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study
Completed
483 enrolled
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
Completed
15 enrolled
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
Completed
376 enrolled 17 charts
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
Completed
86 enrolled
Novel Prognostic Markers in Renal Cancer
Completed
182 enrolled
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Completed
347 enrolled
Renimage
Completed
26 enrolled
VHLimage
Completed
22 enrolled
Everolimage
Completed
13 enrolled
BANN
Completed
40 enrolled
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Completed
135 enrolled
LiangAH
Completed
15 enrolled
Fear of Cancer Recurrence in Genitourinary Cancer
Completed
500 enrolled
Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)
Completed
48 enrolled 36 charts